Real-World Infusion Experience with Ublituximab in ENABLE, the Phase 4 Observational Study By admin / 02/06/2026
Study Design of a Phase 2 Ublituximab Dose-Confirmation Study in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS I By admin / 02/06/2026
